Jacopo Baglieri

2PUBLICATIONS
9CO-AUTHORS
Gene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 13, 2021
Immunotherapy-based targeting of MSLN+ activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis.

Takahiro Nishio, Yukinori Koyama, Xiao Liu

|Jul 27, 2020
Liver fibrosis: Pathophysiology and clinical implications.

Jennifer Berumen, Jacopo Baglieri, Tatiana Kisseleva

Pageof 1